Journal Guide
Publishing in Cancer Research: Fit, Timeline & Submission Guide
Oncology research: tumor biology, therapeutics, and translational science
Should you submit here?
Submit if present finding advancing cancer understanding. Be careful if cR expects cancer significance.
16.6
Impact Factor (2024)
~15-20%
Acceptance Rate
~100-130 days median
Time to First Decision
Submission guide
Cancer Research Submission Guide: Requirements & What Editors Want
A practical Cancer Research submission guide covering package readiness, broad-oncology fit, and what to tighten before upload.
Journal assessment
Is Cancer Research a Good Journal? Impact, Scope, and Fit
Cancer Research (IF 16.6, AACR) is the default top venue for basic cancer biology. Here is who should submit and how it compares to Cancer Cell, Cancer Discovery, and Clinical Cancer Research.
Desk rejection
How to Avoid Desk Rejection at Cancer Research
How to avoid desk rejection at Cancer Research: mechanism, oncology consequence, and stronger translational grounding.
What Cancer Res. Publishes
Cancer Research published by the American Association for Cancer Research is one of the most selective and influential primary research journals in oncology. With JIF 16.6 and Q1 ranking in Oncology, CR emphasizes rigorous oncology research with clinical relevance. The journal publishes research on tumor biology, cancer therapeutics, and translational cancer science. Critically: CR values research with clear cancer significance and clinical translation potential. Mechanistic studies of interesting pathways without cancer context are less competitive. The journal seeks papers advancing cancer understanding or therapy.
- Tumor biology: transformation, progression, metastasis, angiogenesis
- Oncogenes and suppressors: genetic drivers, mutation effects, pathways
- Immunotherapy: immune mechanisms, checkpoint inhibitors, cellular therapies
- Targeted therapy: small molecule inhibitors, biomarkers, precision medicine
- Cancer metabolism: metabolic reprogramming, dependencies, opportunities
- Drug resistance: mechanisms, prediction, overcoming resistance
- Biomarkers: predictive, prognostic, response prediction
- Translational research: from model systems to clinical trials
Editor Insight
“Cancer Research publishes oncology research with clear cancer significance and translational potential. We seek rigorous studies validating mechanisms in vivo with clinical relevance.”
What Cancer Res. Editors Look For
Cancer mechanism with clear relevance to tumor biology or therapy
Present finding advancing cancer understanding. Novel oncogenic pathway? New resistance mechanism? Therapeutic opportunity? Show cancer significance.
Rigorous experimental validation in cell lines and animal models
Validate in 2D and 3D cell culture, xenograft or genetically engineered mouse models. In vivo validation crucial.
Mechanistic understanding of cancer process or therapeutic effect
Explain mechanisms. How does mutation drive transformation? What mediates resistance? Mechanistic insight essential.
Clinical correlation or translational pathway
Connect to patient tumors, clinical outcomes, or therapeutic strategy. Translation matters.
Comparison with existing understanding or therapeutic approaches
Show how findings differ from current knowledge. What advantages for therapy?
Why Papers Get Rejected
These patterns appear repeatedly in manuscripts that don't make it past Cancer Res.'s editorial review:
Cancer mechanism without clinical relevance or therapeutic potential
CR expects cancer significance. Interesting biology alone insufficient. How does finding matter for cancer patients?
Cell line studies without animal model or in vivo validation
In vivo validation essential for CR. Cell lines can be misleading. Show effect in animals or tumors.
No mechanistic explanation of cancer phenotype or therapeutic effect
Describe mechanisms. What molecular pathways? What signaling events? Mechanism crucial.
No attempt to translate findings to therapy or clinical outcome
CR values translational research. How could finding improve cancer treatment? What's clinical pathway?
Incomplete comparison with existing therapeutic approaches
Show how finding differs from current strategies. Why is this advance important?
Does your manuscript avoid these patterns?
The Free Readiness Scan reads your full manuscript against Cancer Res.'s criteria and flags the specific issues most likely to cause rejection.
Insider Tips from Cancer Res. Authors
Novel therapeutic targets and drug sensitivity predictors highly competitive
Discoveries enabling new therapies or predicting response have immediate clinical relevance.
Resistance mechanisms and overcoming resistance increasingly valued
Drug resistance remains major clinical problem. Understanding and overcoming resistance highly competitive.
Patient-derived xenografts and human tumor models trending
More realistic tumor models (patient tumors, organoids) increasingly important.
Immunotherapy mechanisms and immune checkpoint biology valued
Understanding immunotherapy resistance and optimization increasingly important.
Precision medicine and genomic-based stratification competitive
Genomics-guided therapy and patient stratification increasingly prominent.
The Cancer Res. Submission Process
Manuscript preparation
Prep6,000-9,000 words with 6-8 figures. Include cancer mechanism/therapy description, cell line and animal model validation, mechanistic studies, clinical correlation, comparison with existing approaches.
Submission via AACR system
Day 0Submit at https://cancerres.aacrjournals.org/. Required: manuscript emphasizing cancer significance and translational potential, figures showing mechanism and validation.
Editorial assessment
1-2 weeksEditor assesses cancer novelty and clinical significance. Papers lacking in vivo validation or cancer relevance face lower priority. Selective desk rejection ~40-50%.
Peer review
100-130 days2-3 cancer biology experts assess novelty, experimental rigor, mechanistic understanding, and clinical relevance. First decision 100-130 days.
Revision and publication
Revision: 4-8 weeksRevisions often request additional in vivo data, mechanism studies, or clinical correlation. Publication 2-4 weeks after acceptance.
Cancer Res. by the Numbers
| 2024 Impact Factor | 11.2 |
| 5-Year Impact Factor | 11.7 |
| Acceptance rate | ~15-20% |
| Desk rejection rate | ~40-50% |
| Median first decision | ~115 days |
| Open access option | $4,000 USD |
| Publisher | American Association for Cancer Research |
| Founded | 1941 |
Before you submit
Cancer Res. accepts a small fraction of submissions. Make your attempt count.
Start with the Free Readiness Scan. Unlock the Full AI Diagnostic for $29. If you need deeper scientific feedback, choose Expert Review. The full report is calibrated to Cancer Res..
Article Types
Research Article
6,000-9,000 wordsCancer research with mechanism and translational relevance
Brief Communication
3,500-4,500 wordsSignificant cancer finding
Landmark Cancer Res. Papers
Papers that defined fields and changed science:
- Oncogenic pathway discoveries (various) - tumor driver mechanisms
- Immunotherapy resistance mechanisms (2010s+) - overcoming resistance
- Precision medicine biomarkers (2010s+) - predicting therapy response
- Synthetic lethality and drug combinations (2010s+) - combination therapy rationale
Preparing a Cancer Res. Submission?
Get pre-submission feedback from reviewers who've published in Cancer Res. and know exactly what editors look for.
Run Free Readiness ScanNeed expert depth? See Expert Review Options
Primary Fields
Browse by Field
Related Journal Guides
- Publishing in Nature
- Publishing in Cell
- Publishing in Cancer Cell
- Publishing in Cell Reports
- Publishing in Clinical Cancer Research
Latest Journal-Specific Guides
- Submission guideCancer Research Submission Guide: Requirements & What Editors WantA practical Cancer Research submission guide covering package readiness, broad-oncology fit, and what to tighten before upload.
- Journal assessmentIs Cancer Research a Good Journal? Impact, Scope, and FitCancer Research (IF 16.6, AACR) is the default top venue for basic cancer biology. Here is who should submit and how it compares to Cancer Cell, Cancer Discovery, and Clinical Cancer Research.
- Desk rejectionHow to Avoid Desk Rejection at Cancer ResearchHow to avoid desk rejection at Cancer Research: mechanism, oncology consequence, and stronger translational grounding.
- Review timelineCancer Research Review Time: What Authors Can Actually ExpectCancer Research can make an early decision quickly, but the useful issue is whether the paper is mechanistic enough for AACR's flagship biology audience.
More Guides for This Journal
- Acceptance rateCancer Research Acceptance Rate: What Authors Can UseCancer Research does not publish a strong official acceptance rate. The better submission question is whether the paper delivers a real mechanistic cancer advance for a broad AACR readership.
- Impact factorCancer Research Impact Factor 2026: Ranking, Quartile & What It MeansCancer Research impact factor is 16.6. Five-year JIF is 13.4. Q1, rank 16/326. See the trend and what it means for authors.
- Publishing costsCancer Research APC and Open Access: AACR Pricing Logic, Page Charges, and When Gold OA Is Worth ItCancer Research APC runs about $4,200 for AACR members or $5,000 for nonmembers, with page charges on subscription papers.
- Submission processCancer Research Submission Process: What Happens From Upload to First DecisionA practical Cancer Research submission process guide covering what happens after upload, what editors test first, and where oncology papers usually lose momentum.
- Manuscript prepCancer Research Cover Letter: What Editors Actually Need to SeeCancer Research editors are screening for mechanistic insight into cancer biology, not just strong tumor data. A strong cover letter makes that depth obvious fast.
- Publishing guideCancer Research Formatting Requirements: Complete Author GuideCancer Research limits Articles to 5,000 words with a 250-word structured abstract and up to 7 figures. References use AACR numbered style with parenthetical citations, and a Significance statement is mandatory for all research articles.
Ready to submit to Cancer Res.?
A desk rejection costs months. Get expert feedback before you submit, from scientists who know exactly what Cancer Res. editors look for.
Avoid Desk Rejection
Get expert pre-submission review before you submit to Cancer Res.. 3-7 day turnaround.
Manuscript Rejected?
Expert revision help to strengthen your manuscript and resubmit with confidence.
Reviewer Response Help
Get expert guidance crafting your response to Cancer Res. reviewers.
Reference library
Compare Cancer Res. with the broader publishing context
This journal guide is the best starting point for Cancer Res.. The reference library covers the surrounding questions authors usually ask next: whether the package is ready, what drives desk rejection, how neighboring journals compare, and what the submission constraints look like across the field.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Need field-expert depth? See Expert Review Options